BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 326636)

  • 1. Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.
    Klockars M; Reitamo S; Reitamo JJ; Möller C
    Gut; 1977 May; 18(5):377-81. PubMed ID: 326636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.
    Pruzanski W; Marcon N; Ottaway C; Prokipchuk E
    Am J Dig Dis; 1977 Nov; 22(11):995-8. PubMed ID: 920710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical identification of lysozyme in pseudopyloric gland metaplasia in Crohn's disease.
    Geboes K; Van den Oord JJ; Rutgeerts P; Desmet VJ; Vantrappen G
    Hepatogastroenterology; 1983 Aug; 30(4):158-60. PubMed ID: 6354900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysozyme gene expression in inflammatory bowel disease.
    Stamp GW; Poulsom R; Chung LP; Keshav S; Jeffery RE; Longcroft JA; Pignatelli M; Wright NA
    Gastroenterology; 1992 Aug; 103(2):532-8. PubMed ID: 1634071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Hylander E; Hansen NE; Karle H; Janrum S
    Scand J Gastroenterol; 1976; 11(2):213-7. PubMed ID: 1265442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
    S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR; Perrotto JL; Isselbacher KJ
    N Engl J Med; 1975 Feb; 292(8):395-7. PubMed ID: 1110725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
    Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.
    Singer II; Kawka DW; Schloemann S; Tessner T; Riehl T; Stenson WF
    Gastroenterology; 1998 Aug; 115(2):297-306. PubMed ID: 9679035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment.
    Leonard N; Bishop AE; Polak JM; Talbot IC
    J Clin Pathol; 1998 Oct; 51(10):750-3. PubMed ID: 10023337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Peeters TL; Vantrappen G; Geboes K
    Gut; 1976 Apr; 17(4):300-5. PubMed ID: 773792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
    Thompson JS; Burnett DA; Markin RS; Vaughan WP
    Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine decarboxylase in colonic mucosa from patients with moderate or severe Crohn's disease and ulcerative colitis.
    Ricci G; Stabellini G; Bersani G; Marangoni G; Fabbri P; Gentili G; Alvisi V
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):903-4. PubMed ID: 10514125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.
    Fahlgren A; Hammarström S; Danielsson A; Hammarström ML
    Clin Exp Immunol; 2003 Jan; 131(1):90-101. PubMed ID: 12519391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease.
    O'Morain C; Smethurst P; Levi AJ; Peters TJ
    J Clin Pathol; 1983 Nov; 36(11):1312-6. PubMed ID: 6313772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lysozyme in inflammatory bowel and coeliac disease.
    Mallas E; Terry JM; Asquith P; Cooke WT
    J Clin Pathol; 1976 Jul; 29(7):598-600. PubMed ID: 977770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW; Binder HJ; Spiro HM; Finch SC
    Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.
    Choy MY; Walker-Smith JA; Williams CB; MacDonald TT
    Gut; 1990 Dec; 31(12):1365-70. PubMed ID: 2101599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.